
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2010 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2009 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 19.306.880 | 1.174.375 | 2 | ||
| 2022 | 0 | 12.905.249 | 766.185 | 2 | ||
| 2019 | 0 | 4.435.830 | 793.525 | 1 | ||
| 2010 | 0 | 2.843.859 | 330.000 | 1 | ||
Total number of partners: 92
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 92
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | An Artificially Intelligent Diagnostic Assistant for gastric inflammation | AIDA | participant | 6.334.804 | 15 |
| 2023-01-01 | A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways | ONCOSCREEN | participant | 12.972.076 | 40 |
| 2022-12-01 | Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time | ONCOVALUE | participant | 6.953.004 | 11 |
| 2022-06-01 | Pain relief in palliative care of cancer using home-based neuromodulation and predictive biomarkers | PAINLESS | participant | 5.952.245 | 19 |
| 2019-04-01 | Bridging the gap between Mind, Brain and Body: exosome role and monitoring | MindGAP | participant | 4.435.830 | 6 |
| 2010-01-01 | Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer | EpiDiaCan | participant | 2.843.859 | 7 |